Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT05496920
Eligibility Criteria:
Inclusion Criteria:
* Adults (\>18 years) able to provide informed consent for inclusion, willing and able to undergo a PET/CT for the detection or staging of cancer.
* Individuals undergoing a PET/CT with 18F-FDG for the investigation of known or suspected NSCLC.
* Upper fasting plasma glucose levels of \<8.3 mmol/L (\<150 mg/dL) (as measured \>30 mins prior to the administration of the radiopharmaceutical).
Exclusion Criteria:
* Patients who are unable to consent to a second study-specific examination
* Patients with claustrophobia requiring medication.
* Patients who commence active treatment of a cancer or other pathology between scans.
* Patients who have not fasted for \> 4 hours prior to the study.
* Insulin dependent diabetics.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05496920
Study Brief:
Protocol Section:
NCT05496920